Literature DB >> 29611250

Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity.

S Yoowannakul1, K Tangvoraphonkchai2, S Vongsanim2, A Mohamed1, A Davenport1.   

Abstract

BACKGROUND: There is no universal consensus definition of sarcopenia, although there is agreement that sarcopenia is a risk factor for mortality in haemodialysis (HD) patients. We aimed to determine the effect of using different operational definitions in a multiracial group of HD patients.
METHODS: We measured hand grip strength (HGS) and appendicular lean mass (ALM) by segmental bioimpedance using the Foundation for the National Institutes of Health Sarcopenia Project (FNIH), European Working Group on Sarcopenia (EWGS) and Asian Working Group on Sarcopenia definitions for HGS weakness and loss of appendicular lean mass.
RESULTS: In total, there were 600 HD patients: 373 men (62.2%), mean (SD) age 66.3 (14.7) years, 45.6% diabetic, ethnicity: 281 (48.5%) White, 167 (27.8%) Asian and 149 (24.8%) Black. On HGS criteria, 90.5% of Asian women and 88.5% of Asian men were weak according to EWGS compared to 62.3% of Black women and 52.5% of Black men and 64.5% of White women and 69.1% of White men by FNIH criteria (P < 0.001). On adding appendicular lean mass, the prevalence of sarcopenia was 68.3% for Asian, 27.1% for Black and 36.6% for White women by FNIH and 59.6% Asian, 21.3% Black and 39.9% White men by EWGS criteria.
CONCLUSIONS: Current definitions of sarcopenia report a greater prevalence of muscle weakness compared to appendicular muscle loss in female compared to male HD patients and this is greater for Asian compared to Black and White patients. Because HGS weakness is a greater risk for death, definitions of sarcopenia may underestimate risk in HD patients.
© 2018 The British Dietetic Association Ltd.

Entities:  

Keywords:  chronic kidney disease; haemodialysis; hand grip strength; muscle strength; sarcopenia

Mesh:

Year:  2018        PMID: 29611250     DOI: 10.1111/jhn.12555

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  14 in total

1.  A Pilot Study of Racial Differences in the Current Definition of Sarcopenia among Liver Transplant Candidates.

Authors:  Tomoki Sempokuya; Leigh Yokoyama-Arakaki; Linda L Wong; Sumodh Kalathil
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

2.  The cut-off values of handgrip strength and lean mass index for sarcopenia among patients on peritoneal dialysis.

Authors:  Xiao Xu; Zhikai Yang; Tiantian Ma; Ziqian Li; Yuan Chen; Yingdong Zheng; Jie Dong
Journal:  Nutr Metab (Lond)       Date:  2020-10-08       Impact factor: 4.169

Review 3.  Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis.

Authors:  Xiaoyu Shu; Taiping Lin; Hui Wang; Yanli Zhao; Tingting Jiang; Xuchao Peng; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-05       Impact factor: 12.910

4.  Physical Function in Kidney Transplantation: Current Knowledge and Future Directions.

Authors:  Dia Yang; Lucy Robinson; Christian Selinski; Thalia Bajakian; Christina Mejia; Meera Nair Harhay
Journal:  Curr Transplant Rep       Date:  2020-05-02

5.  Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting.

Authors:  Foon Yin Fung; Yi Ling Eileen Koh; Rahul Malhotra; Truls Ostbye; Ping Yein Lee; Sazlina Shariff Ghazali; Ngiap Chuan Tan
Journal:  BMC Geriatr       Date:  2019-04-29       Impact factor: 3.921

6.  Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A Cross-Sectional Study.

Authors:  Qin Yang; Yingxiao Zhang; Qinglian Zeng; Chan Yang; Jiale Shi; Chunlin Zhang; Xia Ni; Zhipeng Du; Ziwei Tang; Jinbo Hu; Xuemei Li; Jiahui Cai; Qifu Li; Qingfeng Cheng
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-13       Impact factor: 3.168

7.  The impact of muscle mass loss and deteriorating physical function on prognosis in patients receiving hemodialysis.

Authors:  Mineaki Kitamura; Takahiro Takazono; Kosei Yamaguchi; Satoko Notomi; Kenji Sawase; Takashi Harada; Satoshi Funakoshi; Hiroshi Mukae; Tomoya Nishino
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

8.  Study on the relationship between sarcopenia and its components and anorexia in elderly maintenance haemodialysis patients.

Authors:  Chao Li; Lin Chen; Li He; Yingjun Zhang; Hui Chen; Yuan Liu; Sikai Tang; Haotian Zheng
Journal:  Nurs Open       Date:  2021-12-14

9.  Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.

Authors:  Masafumi Kurajoh; Katsuhito Mori; Mizuki Miyabe; Shota Matsufuji; Akane Kizu; Yoshihiro Tsujimoto; Masanori Emoto
Journal:  Front Med (Lausanne)       Date:  2022-02-07

Review 10.  Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment.

Authors:  Varvara Chatzipetrou; Marie-Josée Bégin; Mélany Hars; Andrea Trombetti
Journal:  Calcif Tissue Int       Date:  2021-08-12       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.